Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 162

1.

Serum apoptosis markers in acute liver failure: a pilot study.

Rutherford AE, Hynan LS, Borges CB, Forcione DG, Blackard JT, Lin W, Gorman AR, Shaikh OS, Reuben A, Harrison E, Reddy KR, Le WM, Chung RT; ALF Study Group.

Clin Gastroenterol Hepatol. 2007 Dec;5(12):1477-83. Epub 2007 Oct 29.

PMID:
17967565
2.

Increased serum soluble Fas in patients with acute liver failure due to paracetamol overdose.

Tagami A, Ohnishi H, Hughes RD.

Hepatogastroenterology. 2003 May-Jun;50(51):742-5.

PMID:
12828076
3.

Tumour necrosis factor-alpha and soluble Fas ligand as biomarkers in non-acetaminophen-induced acute liver failure.

Singhal S, Chakravarty A, Das BC, Kar P.

Biomarkers. 2009 Aug;14(5):347-53. doi: 10.1080/13547500903013664.

PMID:
19505222
4.
5.

Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure.

Lin SD, Kawakami T, Ushio A, Sato A, Sato S, Iwai M, Endo R, Takikawa Y, Suzuki K.

J Gastroenterol Hepatol. 2006 Feb;21(2):374-80.

PMID:
16509861
6.
7.

Soluble Fas and soluble Fas ligand levels in patients with acute hepatic failure.

Nakae H, Narita K, Endo S.

J Crit Care. 2001 Jun;16(2):59-63.

PMID:
11481600
8.

Serum hepatocyte growth factor and vascular endothelial growth factor in children with acute liver failure.

Aw MM, Mitry RR, Hughes RD, Dhawan A.

J Pediatr Gastroenterol Nutr. 2007 Feb;44(2):224-7.

PMID:
17255836
9.

Involvement of IL-18 and soluble fas in patients with postoperative hepatic failure.

Nakae H, Zheng YJ, Wada H, Tajimi K, Endo S.

Eur Surg Res. 2003 Mar-Apr;35(2):61-6.

PMID:
12679613
10.

Significant correlation between surgical stress of hepatectomy and changes in the serum levels of HGF, IL-6 and soluble Fas in patients with viral hepatitis.

Gotohda N, Iwagaki H, Ozaki M, Kinoshita T, Konishi M, Nakagohri T, Takahashi S, Saito S, Yagi T, Tanaka N.

Hepatogastroenterology. 2008 Jul-Aug;55(85):1400-3.

PMID:
18795698
11.

Selected apoptotic markers in serum of patients with chronic viral hepatitis C.

Głowacki MK, Cieśla A, Cibor D, Owczarek D, Mach T, Wiliński J, Wiliński B.

Przegl Lek. 2014;71(7):369-73.

PMID:
25338331
12.

Reduced monocyte HLA-DR expression: a novel biomarker of disease severity and outcome in acetaminophen-induced acute liver failure.

Antoniades CG, Berry PA, Davies ET, Hussain M, Bernal W, Vergani D, Wendon J.

Hepatology. 2006 Jul;44(1):34-43.

PMID:
16799971
13.

Plasma Fas ligand, an inducer of apoptosis, and plasma soluble Fas, an inhibitor of apoptosis, in patients with chronic congestive heart failure.

Nishigaki K, Minatoguchi S, Seishima M, Asano K, Noda T, Yasuda N, Sano H, Kumada H, Takemura M, Noma A, Tanaka T, Watanabe S, Fujiwara H.

J Am Coll Cardiol. 1997 May;29(6):1214-20.

14.

An increase of soluble Fas, an inhibitor of apoptosis, associated with progression of COPD.

Yasuda N, Gotoh K, Minatoguchi S, Asano K, Nishigaki K, Nomura M, Ohno A, Watanabe M, Sano H, Kumada H, Sawa T, Fujiwara H.

Respir Med. 1998 Aug;92(8):993-9.

15.

Vascular cell adhesion molecule 1, soluble Fas and hepatocyte growth factor as predictors of mortality in nonagenarians: the Vitality 90+ study.

Kämppä N, Mäkelä KM, Lyytikäinen LP, Peltonen N, Hautamäki J, Seppälä I, Mononen N, Goebeler S, Karhunen PJ, Hervonen A, Hurme M, Jylhä M, Lehtimäki T.

Exp Gerontol. 2013 Nov;48(11):1167-72. doi: 10.1016/j.exger.2013.07.009. Epub 2013 Jul 30.

PMID:
23911532
16.

Relationship of oncogenes (sFas, Bcl-2) and cytokines (IL-10, alfa-TNF) with the activity of systemic lupus erythematosus.

Miret C, Font J, Molina R, Garcia-Carrasco M, Filella X, Ramos M, Cervera R, Ballesta A, Ingelmo M.

Anticancer Res. 2001 Jul-Aug;21(4B):3053-9.

PMID:
11712810
17.

Characterization of soluble FAS, FAS ligand and tumour necrosis factor-alpha in patients with chronic HCV infection.

Raghuraman S, Abraham P, Daniel HD, Ramakrishna BS, Sridharan G.

J Clin Virol. 2005 Sep;34(1):63-70.

PMID:
16087126
18.

Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.

Hsia CY, Huo TI, Chiang SY, Lu MF, Sun CL, Wu JC, Lee PC, Chi CW, Lui WY, Lee SD.

Eur J Surg Oncol. 2007 Mar;33(2):208-12. Epub 2006 Nov 29.

PMID:
17140760
19.

Role of serum soluble Fas/soluble Fas ligand and TNF-alpha on response to interferon-alpha therapy in chronic hepatitis C.

Toyoda M, Kakizaki S, Horiguchi N, Sato K, Takayama H, Takagi H, Nagamine T, Mori M.

Liver. 2000 Jul;20(4):305-11.

PMID:
10959809
20.

Circulating mannan-binding lectin, M-, L-, H-ficolin and collectin-liver-1 levels in patients with acute liver failure.

Laursen TL, Sandahl TD, Støy S, Schiødt FV, Lee WM, Vilstrup H, Thiel S, Grønbaek H; US Acute Liver Failure Study Group.

Liver Int. 2015 Mar;35(3):756-63. doi: 10.1111/liv.12682. Epub 2014 Sep 30.

Supplemental Content

Support Center